Lecanemab Reduced Markers of Amyloid in Early Alzheimer Disease
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with early Alzheimer disease, lecanemab reduced markers of amyloid and resulted in moderately less decline in cognition and function at 18 months, according to a study published online Nov. 29 …
Learn MoreClinician Nudge Ups Initiation of Statin Prescribing in Primary Care
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A clinician nudge alone or combined with a patient nudge can increase initiation of statin prescribing during primary care visits, according to a study published online Nov. 30 in JAMA Cardiology.Srinath Ad…
Learn MoreOveractive Bladder Common in Postacute COVID-19 Syndrome
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Overactive bladder (OAB) symptoms are common in patients recovering from postacute COVID-19 syndrome (PACS), according to a study published online Oct. 26 in the Journal of Multidisciplinary Healthcare.Atha…
Learn More2000 to 2020 Saw Increase in Drug Overdose Death Rates in Seniors
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — From 2000 to 2020, there was an increase in the age-adjusted rates of drug overdose deaths for adults aged 65 years and older, according to a November data brief published by the U.S. Centers for Disease C…
Learn MoreSkills-Training Program Beneficial for Teen Drivers With ADHD
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A computerized skills-training program designed to reduce long glances away from the road is beneficial for teenagers with attention-deficit/hyperactivity disorder (ADHD), according to a study published onl…
Learn MoreUse of New-to-Market Neurologic Medications Reported to Be Low
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Utilization of new-to-market neurologic medications in the privately insured population remains low, according to a study published online Nov. 30 in Neurology.Evan L. Reynolds, Ph.D., from the University o…
Learn MoreTemporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A temporal improvement in COVID-19 standard of care (SOC) has been suggested, which explains improved outcomes from Adaptive COVID-19 Treatment Trial (ACTT)-2 to ACTT-3, according to a study published onlin…
Learn MoreQuality Improvement Collaborative Improving Cancer Screening Postpandemic
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A quality improvement (QI) collaborative can improve cancer screening, according to a study published online Nov. 16 in JAMA Network Open.Rachel Hae-Soo Joung, M.D., from the Northwestern University Feinber…
Learn MoreConvection-Enhanced Delivery of Topotecan Active in Glioblastoma
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastoma, according to a stud…
Learn MoreLas recetas de Valium y Xanax podrían aumentar el riesgo de sobredosis de los jóvenes
MARTES, 29 de noviembre de 2022 (HealthDay News) — Los adolescentes y adultos jóvenes que usan benzodiacepinas podrían tener un mayor riesgo de sobredosis, encuentra un estudio reciente.Entre las benzodiacepinas se encuentran ansiolíticos como Ativan…
Learn More